Bone disease in multiple myeloma: new markers, new treatments

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR.

Leukemia·2016

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study.

Leukemia·2016

Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.

Leukemia·2016

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Leukemia·2015

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group.

Internal medicine journal·2015

Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Internal medicine journal·2015

Continuous glucose monitoring detects spontaneous reactive and fasting hypoglycaemia in cystic fibrosis adults without diabetes.

Internal medicine journal·2026

Association between serum calcium levels and mortality in critically ill patients with gastrointestinal bleeding: a retrospective cohort study.

Internal medicine journal·2026

Stigmatising substance-related language in the electronic health records of hospitalised patients after addiction consult service implementation.

Internal medicine journal·2026

Improving timeliness of lung cancer care through a rapid assessment clinic.

Internal medicine journal·2026

Using artificial intelligence in clinical practice: Royal Australasian College of Physicians position statement.

Internal medicine journal·2026

Stress hyperglycaemia ratio and post-operative delirium after cardiac surgery: a retrospective cohort study of the MIMIC-IV database.

Internal medicine journal·2026

Recent advances in cell therapy for AML/MDS.

International journal of hematology·2026

Therapeutic effects of trans-3-methoxy-β-nitrostyrene in rat model of monocrotaline-induced pulmonary hypertension.

European journal of pharmacology·2026

A dual functional hybrid lipid-polymeric nanoparticle co-loaded coenzyme Q10 and siRNA TNFα for anti-inflammatory skin therapy.

International journal of pharmaceutics·2026

Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis.

Cell reports. Medicine·2026

Preclinical evaluation of entecavir as a fetal hemoglobin inducer using in vitro, in vivo, network pharmacology, and molecular docking approaches.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Extracorporeal photopheresis: A comprehensive review from a transfusion medicine perspective.

Hematology, transfusion and cell therapy·2026

Related Experiment Videos

Bone disease in multiple myeloma: new markers, new treatments

Related Concept Videos

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR.

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study.

Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group.

Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Continuous glucose monitoring detects spontaneous reactive and fasting hypoglycaemia in cystic fibrosis adults without diabetes.

Association between serum calcium levels and mortality in critically ill patients with gastrointestinal bleeding: a retrospective cohort study.

Stigmatising substance-related language in the electronic health records of hospitalised patients after addiction consult service implementation.

Improving timeliness of lung cancer care through a rapid assessment clinic.

Using artificial intelligence in clinical practice: Royal Australasian College of Physicians position statement.

Stress hyperglycaemia ratio and post-operative delirium after cardiac surgery: a retrospective cohort study of the MIMIC-IV database.

Recent advances in cell therapy for AML/MDS.

Therapeutic effects of trans-3-methoxy-β-nitrostyrene in rat model of monocrotaline-induced pulmonary hypertension.

A dual functional hybrid lipid-polymeric nanoparticle co-loaded coenzyme Q10 and siRNA TNFα for anti-inflammatory skin therapy.

Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis.

Preclinical evaluation of entecavir as a fetal hemoglobin inducer using in vitro, in vivo, network pharmacology, and molecular docking approaches.

Extracorporeal photopheresis: A comprehensive review from a transfusion medicine perspective.

Related Experiment Videos

Bone disease in multiple myeloma: new markers, new treatments

Related Concept Videos

Related Articles